Building partnerships
with the NHS

Designed Specifically for the NHS

Skin Analytics have provided teledermatology services for over 5 years and our latest platform, powered by our medical device DERM, builds on all this experience. It enables the NHS to efficiently manage demand by directing people to the most appropriate care pathway.

Skin Analytics platform is designed to

  • Safely reduce referrals and associated costs
  • Improve health outcomes
  • Better clinical governance
  • Improve patient experience
  • Ensure patient’s data is secure

Reducing costs and adding valuable benefits

DERM, our unique AI technology, provides dermatology capacity by identifying 11 different lesion types. These range from malignant and pre-malignant lesions that can be treated if assessed early enough, through to benign lesions where patients can be discharged or referred for further monitoring.

DERM allows for patients to be triaged before they have a face to face appointment with a dermatologist, saving unnecessary hospital appointments for patients and dermatologists. The Skin Analytics system also enables local dermatologists to review referred cases remotely, allowing them to direct patients to the best assessment or treatment option.

NHS Partners

Partner with us

 

  • Our services are only available through our clinical partners in the UK. If you're worried about your skin and haven't been referred to us please speak to a doctor without delay.

 

Patient Safety and Quality Policy

Skin Analytics aims to provide best in class solutions for patients. We work to meet our customers and partners expectations by delivering on our brand vision with innovative and customer focused products and services.

We empower our teams to maintain a culture of innovation and continuous improvement, underpinned by an effective and efficient Quality Management System that complies with statutory and regulatory requirements.

We put safety and outcomes at the heart of what we do, to provide high quality products and services which are reliable, safe and compliant which is why we are so proud to have achieved ISO 13485:2016 compliance. MD 711728. 

Clinical Advisory Committee

Professor Scott Kitchnener

Professor Scott Kitchnener

Committee Chair. Primary Care Medical Service Director

Scott is a qualified specialist in medical leadership and management (FRACMA), a graduate of the AICD, a specialist public health physician (FAFPHM), while remaining a clinician with specialist standing as a general practitioner in rural practice. He has experience in health and education corporate governance and leadership in the private sector, public sector, higher education sector, international and Australian biotech sectors and in the military. His on-going research and experience have been in addressing health issues of developing nations, rural health and workforce, and particularly preventive approaches to public health challenges. 

Dr Niall Wilson

Dr Niall Wilson

Consultant Dermatologist

Niall qualified in Medicine from the University of Liverpool in 1991. He has been an NHS Consultant Dermatologist since 2000. He has special interests in skin cancer, hyperhidrosis and skin disorders in immunosuppressed patients. He has also been involved with postgraduate education for many years and is currently vice chair of the Specialist Advisory Committee for Dermatology, which oversees Dermatology training in the UK.

Dr Lucy Thomas

Dr Lucy Thomas

Consultant Dermatologist

Lucy is a Consultant Dermatologist at the Phoenix Hospital Group in London.

Professor Chris Hyde

Professor Chris Hyde

Health Economics

Chris is a professor of Public Health and Clinical Epidemiology at Exeter University. He is a School lead for research on test evaluation including systematic reviews, economic models and primary research. He leads the Exeter Test Group and is the diagnostics theme lead for PenCLAHRC. He is part of the Peninsula Technology Assessment Group (PenTAG). He directed the team delivering health technology assessments for national policy-making bodies, particularly NICE, from 2009 until 2015 and continues to support it by being the lead on HTAs of tests and through membership of its steering group. He is a long standing member of NICE's Diagnositc Advisory Committee and recently joined the National Screening Committee.

Justin M Ko, MD, MBA

Justin M Ko, MD, MBA

CLINICAL ASSOCIATE PROFESSOR, DERMATOLOGY STANFORD UNIVERSITY

Dr. Ko joined Stanford Medicine in 2012 and serves as Director and Chief of Medical Dermatology for Stanford Health Care (SHC) while also spearheading the dermatology department's efforts around network development, digital health, quality/safety/performance improvement, and value-based care. He is active in a number of leadership roles within the organization including co-chairing the Clinic Advisory Council, a forum of medical and executive leaders of Stanford Health Care’s Ambulatory clinics, and as a Service Medical Director.

His passion for melanoma, early cancer detection, and improving care delivery drives his efforts and research around leveraging advances in machine learning and artifical intelligence to increase the breadth of populations that can be reached. He chairs the American Academy of Dermatology's Task Force Committee on Augmented Intelligence.